Why the study?
What are the 5-year clinical and hemodynamic outcomes of patients undergoing aortic valve replacement with the Lillehei-Kaster prosthesis?
What are the 5-year clinical and hemodynamic outcomes of patients undergoing aortic valve replacement with the Lillehei-Kaster prosthesis?
The Lillehei-Kaster prosthesis in the aortic position demonstrates acceptable 5-year survival and low complication rates, though sizes 14A or smaller may have inadequate functional valve areas.
Answers are grounded in this paper and cite their sources.
Supports selective use in aortic position; leaves open randomized comparisons and size-specific assessments.
From 1972 through 1976, 140 patients underwent aortic valve replacement (AVR) with the Lillehei‐Kaster (LK) prosthesis and 18 additional patients had AVR plus coronary bypass procedures. Follow‐ up information was obtained in 98% of the patients. The operative mortality rate was 7.5% and the actuarial 5‐ year survival rate was, 79%. Two episodes of thromboembolism occurred in 3,645 patient‐months. Prosthesis malfunction or significant hemolysis has not occurred. Postoperative catheterization studies revealed a functional valve area of 0.81 cm 2 with the 14A prosthesis; all other valve areas were greater than 1.1 cm 2 . Continued use of the LK aortic valve prosthesis with warfarin anticoagulation is recommended in sizes greater than 14A.
No takes yet. Share an insight, caveat, or question.
Mayer et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: